On January 4, 2023, the FDA announced that mifepristone will be available in pharmacies that comply with certain requirements. While prescriber certification, patient agreement forms and a new pharmacy certification process remain barriers, the FDA's announcement is a great step in expanding equitable access to medication abortion pills. Through legislative and legal efforts, CAFP has long advocated […]